Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,503 | 379 | 92.8% |
| Education | $659.70 | 7 | 7.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,246 | 104 | $0 (2024) |
| Janssen Biotech, Inc. | $1,849 | 94 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $750.27 | 30 | $0 (2024) |
| UCB, Inc. | $588.57 | 20 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $582.39 | 17 | $0 (2024) |
| Incyte Corporation | $435.88 | 15 | $0 (2024) |
| Lilly USA, LLC | $409.68 | 17 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $342.98 | 12 | $0 (2024) |
| GENZYME CORPORATION | $342.50 | 14 | $0 (2024) |
| PFIZER INC. | $313.69 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,814 | 109 | Janssen Biotech, Inc. ($717.40) |
| 2023 | $2,383 | 92 | Janssen Biotech, Inc. ($588.11) |
| 2022 | $2,434 | 107 | ABBVIE INC. ($694.85) |
| 2021 | $1,532 | 78 | AbbVie Inc. ($807.87) |
All Payment Transactions
386 individual payment records from CMS Open Payments — Page 4 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/08/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.97 | General |
| Category: Immunology | ||||||
| 05/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $36.22 | General |
| Category: Immunology | ||||||
| 05/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: ONCOLOGY | ||||||
| 04/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $128.72 | General |
| Category: Immunology | ||||||
| 04/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Immunology | ||||||
| 04/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $0.40 | General |
| Category: Immunology | ||||||
| 04/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $2.57 | General |
| Category: DERMATOLOGY | ||||||
| 04/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: DERMATOLOGY | ||||||
| 04/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 04/03/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug), Absorica LD | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Dermatology | ||||||
| 04/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 03/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/28/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: Dermatology | ||||||
| 03/28/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $2.40 | General |
| Category: DERMATOLOGY | ||||||
| 03/27/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Immunology | ||||||
| 03/27/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $11.68 | General |
| 03/22/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Immunology | ||||||
| 03/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $9.04 | General |
| 03/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.31 | General |
| Category: Immunology | ||||||
| 03/05/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $123.97 | General |
| Category: Inflammation & Immunology | ||||||
| 02/27/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $15.62 | General |
| 02/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.93 | General |
| Category: DERMATOLOGY | ||||||
| 02/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,347 | 4,795 | $628,165 | $169,769 |
| 2022 | 21 | 2,450 | 4,985 | $679,410 | $184,121 |
| 2021 | 21 | 2,505 | 4,755 | $573,572 | $191,643 |
| 2020 | 22 | 2,390 | 4,618 | $526,134 | $171,775 |
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 570 | 790 | $153,478 | $42,275 | 27.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 303 | 374 | $81,696 | $21,676 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 180 | 250 | $68,529 | $19,617 | 28.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 328 | 488 | $70,561 | $15,870 | 22.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 155 | 181 | $43,757 | $12,289 | 28.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 63 | 80 | $29,404 | $8,862 | 30.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 261 | 1,997 | $27,930 | $8,680 | 31.1% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 28 | 28 | $25,890 | $8,241 | 31.8% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 25 | 26 | $22,521 | $6,934 | 30.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 86 | 151 | $16,405 | $5,304 | 32.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 31 | 41 | $15,909 | $3,923 | 24.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 72 | 72 | $17,742 | $3,921 | 22.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 101 | 113 | $13,702 | $3,616 | 26.4% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 31 | 36 | $19,149 | $3,117 | 16.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $7,614 | $2,002 | 26.3% |
| 10040 | Acne surgery | Office | 2023 | 11 | 12 | $3,018 | $919.75 | 30.5% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 11 | 12 | $3,258 | $840.46 | 25.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 22 | 22 | $3,446 | $813.76 | 23.6% |
| 69100 | Biopsy of ear | Office | 2023 | 15 | 16 | $3,361 | $650.22 | 19.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 20 | $600.00 | $167.11 | 27.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 18 | 65 | $195.00 | $51.00 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 581 | 778 | $154,723 | $42,509 | 27.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 300 | 390 | $86,859 | $23,437 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 212 | 264 | $74,448 | $20,657 | 27.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 329 | 503 | $71,929 | $16,961 | 23.6% |
About Geraldine Emanuel, ARNP
Geraldine Emanuel, ARNP is a Nurse Practitioner healthcare provider based in Palm Beach Gardens, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023065083.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Geraldine Emanuel, ARNP has received a total of $9,163 in payments from pharmaceutical and medical device companies, with $2,814 received in 2024. These payments were reported across 386 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($8,503).
As a Medicare-enrolled provider, Emanuel has provided services to 9,692 Medicare beneficiaries, totaling 19,153 services with total Medicare billing of $717,308. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Palm Beach Gardens, FL
- Active Since 05/27/2006
- Last Updated 10/28/2020
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1023065083
Products in Payments
- TREMFYA (Drug) $1,661
- SKYRIZI (Biological) $1,194
- DUPIXENT (Biological) $1,092
- RINVOQ (Biological) $663.58
- Bimzelx (Biological) $439.99
- TALTZ (Drug) $409.68
- Sotyktu (Drug) $342.98
- OPZELURA (Drug) $320.03
- VTAMA (Drug) $307.47
- HUMIRA (Biological) $292.56
- ILUMYA (Biological) $224.34
- ADBRY (Biological) $203.45
- REMICADE (Biological) $188.36
- EUCRISA (Drug) $170.50
- Cimzia (Drug) $148.58
- CIBINQO (Drug) $143.19
- Otezla (Drug) $133.36
- COSENTYX (Biological) $114.95
- COSENTYX (Drug) $105.65
- STELARA (Biological) $105.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Palm Beach Gardens
Newah Mofor-Tawo
Nurse Practitioner — Payments: $12,802
Kathryn Chambers, Aocnp, AOCNP
Nurse Practitioner — Payments: $8,850
Judy Barrett, Nurse Practitioner, NURSE PRACTITIONER
Nurse Practitioner — Payments: $7,966
Shanna Stone, Arnp, ARNP
Nurse Practitioner — Payments: $7,272
Casey Turek
Nurse Practitioner — Payments: $6,279
Mrs. Tara Smith, Arnp, ARNP
Nurse Practitioner — Payments: $5,949